Antihypertensive medication and the risk of acute pancreatitis: The European case-control study on drug-induced acute pancreatitis (EDIP)

Scandinavian Journal of Gastroenterology

Volumn 41, Issue 12, 2006, Pages 1484-1490

  Eland, Ingo A ^a   Sundström, Anders ^b   Velo, Giancarlo P ^c   Andersen, Morten ^d   Sturkenboom, Miriam C J M ^a   Langman, Michael J S ^e   Stricker, Bruno H Ch ^a   Wiholm, Beje ^f  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b MEDICAL PRODUCTS AGENCY   (Sweden)

^c UNIVERSITY OF VERONA   (Italy)

^d UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^e QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acute pancreatitis; Antihypertensive agents; Drug toxicity; Pharmacoepidemiology

Indexed keywords

ALCOHOL; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; POTASSIUM SPARING DIURETIC AGENT; THIAZIDE DIURETIC AGENT;

ACUTE PANCREATITIS; ADULT; ALCOHOL CONSUMPTION; ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG CYTOTOXICITY; DRUG DOSE REGIMEN; DRUG INDUCED DISEASE; DRUG USE; FEMALE; HAZARD ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT INFORMATION; PRIORITY JOURNAL; RISK ASSESSMENT; STRUCTURED INTERVIEW;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; CASE-CONTROL STUDIES; DIURETICS; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATITIS;

EID: 33751106163     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520600761676     Document Type: Article

References (27)

1. McKay CJ, Evans S, Sinclair M, Carter CR, Imrie CW. High early mortality rate from acute pancreatitis in Scotland, 1984-1995. Br J Surg 1999;86:1302-5.
2. Eland IA, Sturkenboom MJCM, Wilson JHP, Stricker BHC. Incidence and mortality of acute pancreatitis between 1985 and 1995. Scand J Gastroenterol 2000;35:1110-6.
3. Corfield AP, Cooper MJ, Williamson RC. Acute pancreatitis: a lethal disease of increasing incidence. Gut 1985;26:724-9.
4. Steinberg W, Tenner S. Acute pancreatitis. N Engl J Med 1994;330:1198-210.
5. Wilmink T, Frick TW. Drug-induced pancreatitis. Drug Safety 1996;14:406-23.
6. Carnovale A, Esposito P, Bassano P, Russo L, Uomo G. Enalapril-induced acute recurrent pancreatitis. Dig Liver Dis 2003;35:55-7.
7. Jeandidier N, Klewansky M, Pinget M. Captopril-induced acute pancreatitis. Diabetes Care 1995;18:410-1.
8. Maringhini A, Termini A, Patti R, Ciambra M, Biffarella P, Pagliaro L. Enalapril-associated acute pancreatitis: recurrence after rechallenge. Am J Gastroenterol 1997;92:166-7.
9. Gallego-Rojo FJ, Gonzalez-Calvin JL, Guilarte J, Casado-Caballero FJ, Bellot V. Perindopril-induced acute pancreatitis. Dig Dis Sci 1997;42:1789-91.
10. Stepani P, Mezieres P, Tossou H, Delcenserie R, Andrejak M, Bories C. Association methychlothiazide-triamterene et pancreatite aigue: un cas avec reintroduction positive. Gastroenterol Clin Biol 2000;24:974-5.
11. Jones PE, Oelbaum MH. Frusemide-induced pancreatitis. Br Med J 1975;1:133-4.
12. Call T, Malarkey WB, Thomas FB. Acute pancreatitis secondary to furosemide with associated hyperlipidemia. Am J Dig Dis 1977;22:835-8.
13. Stenvinkel P, Alvestrand A. Loop diuretic-induced pancreatitis with rechallenge in a patient with malignant hypertension and renal insufficiency. Acta Med Scand 1988;224:89-91.
14. Organization WH. Anatomical therapeutical classification (ATC) index including defined daily dosage (DDD) for plain substances. Oslo, Norway: Word Health Organization 1994.
15. National Institutes of Health NHL, and Blood Institute. Clinical guidelines on the indentification, evaluation, and treatment of overweight and obesity in adults: the evidence report. Bethesda (MD): National Institutes of Health; 1998.
16. Jones MF, Caldwell JR. Acute hemorrhagic pancreatitis associated with administration of chlorthalidone. N Engl J Med 1962;267:1029-31.
17. Minkowitz S, Soloway HB, Hall JE, Yermakov V. Fatal hemorrhagic pancreatitis following chlorothiazide administration in pregnancy. Obstet Gynecol 1964;24:337-42.
18. Moir DC. Drug-associated acute pancreatitis. Lancet 1978;2:369-70.
19. Bourke JB, McIllmurray MB, Mead GM, Langman MJ. Drug-associated primary acute pancreatitis. Lancet 1978;1:706-8.
20. Tilkemeier P, Thompson PD. Acute pancreatitis possibly related to enalapril. N Engl J Med 1988;318:1275-6.
21. Dabaghi S. ACE inhibitors and pancreatitis. Ann Intern Med 1991;115:330-1.
22. Roush MK, McNutt RA, Gray TF. The adverse effect dilemma: quest for accessible information. Ann Intern Med 1991;114:298-9.
23. Israili ZH, Hall WD. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology. Ann Intern Med 1992;117:234-42.
24. Griesbacher T. Kallikrein-kinin system in acute pancreatitis: potential of B(2)-bradykinin antagonists and kallikrein inhibitors. Pharmacology 2000;60:113-20.
25. Werth B, Kuhn M, Hartmann K, Reinhart WH. Medikamentos induzierte Pankreatitiden: Erfahrungen der Schweizerischen Arzneimittel- Nebenwirkungszentrale (SANZ) 1981-1993. Schweiz Med Wochenschr 1995;125:731-4.
26. Lancashire RJ, Cheng K, Langman MJS. Discrepancies between population-based data and adverse reaction reports in assessing drugs as causes of acute pancreatitis. Aliment Pharmacol Ther 2003;17:887-93.
27. Cheng R, Mamdani M, Jackevicius C, Tu K. Associations between ACE-inhibitors and acute pancreatitis in the elderly. Ann Pharmacother 2003;37:994-8.